Although the actual role of IL-6 in AE ILD remains elusive, we assumed that IL-6 could be an important plasma biomarker because IL-6 possesses both the nature of pro-inflammatory and pro-fibrotic mediators. The gene discussed is IL6; the disease is interstitial lung disease.